Mobile Gamma Cameras Market Size is likely to expand considerably from 2022 to 2028. This growth is driven by the availability of multi-purpose gamma imaging cameras with enhanced diagnostics capabilities to aid the treatment of diseases such as cancer. The rising prevalence of chronic diseases will further drive industry growth, as the product can help radiologists conduct scintigraphy scans to offer detailed diagnoses about the functioning of the heart, lungs, and other body parts. Gamma cameras refer to medical apparatus that can detect gamma rays emitted from the body following the administration of radioactive drugs, thus producing images of organs being investigated. Portable imaging with single-head gamma cameras can substantially reduce infection risks as they limit the transportation of patients, thus limiting the infection spread and lowering hospital stays.
Rapid technological advancement in nuclear imaging is one of the prominent trends fostering the mobile gamma cameras market outlook through 2022-2028. For example, the emergence of solid-state technology is set to unlock the potential of portable gamma cameras and ensure greater accessibility to nuclear imaging, thus reducing healthcare costs associated with healthcare-acquired infections. In addition, the mounting incidence of cancer will further amplify industry expansion in the upcoming years, given the use of gamma camera devices in radio-guided surgery for cancer treatment.
Considering application, the mobile gamma cameras market from the breast imaging segment will amass considerable profits by 2028. Growth from this segment is due to the growing elderly population and the escalating prevalence of cancer among the burgeoning number of obese people worldwide. According to the CDC, above 90% of new obesity-related cancers are diagnosed among men and women aged 50 years and above, thus augmenting the need for mobile gamma camera equipment. Based on end-user, the ambulatory surgical centers segment will register an appreciable revenue over the estimated timeline. This can be credited to the myriad advantages of treatment at ASCs over hospitals, including low costs and reduced risks of infection.
Asia Pacific mobile gamma cameras market is poised to depict a high growth rate through 2028, owing to the surging cases of pancreatic cancer in emerging economies such as India. Given the significant application scope of nuclear medicine in the treatment of aggressive tumors like pancreatic adenocarcinoma, the rising disease incidence will drive the regional market share. Likewise, the considerable increase in healthcare spending, coupled with the high burden of cardiac diseases among urban patients in China, will also proliferate the demand for mobile gamma cameras in the upcoming years.
Key mobile gamma cameras industry players include Spectrum Dynamics Medical (Biosensors International), Dilon Technologies, Beijing Hamamatsu Photon Techniques, GAEDE Medizinsysteme, Digirad Corporation, and DDD-Diagnostic A/S, among others. These companies are focusing on new product launches, acquisitions, and mergers to reinforce their footprint across the competitive market.
The novel coronavirus pandemic has resulted in a significant decline in the treatment of renal diseases worldwide. During the peak of the pandemic, there was a steep reduction in the number of patients with kidney failure accessing treatment such as transplant and dialysis. Such factors may have asserted a negative influence on the steady growth of the mobile gamma cameras industry over the past months.
However, rising concerns regarding post-COVID-19 complications on the heart and other body parts may help the industry regain traction over the forthcoming years. The virus can affect the inner surfaces of arteries and veins, thereby compromising blood flow to the body parts, which could impel the need for mobile gamma camera devices to generate functional scans of organs.
Market, By Type
Market, By Application
Market, By End-users
The above information is provided for the following regions and countries: